Previous close | 2,630.60 |
Open | 2,649.90 |
Bid | 0.00 x 0 |
Ask | 2,500.70 x 0 |
Day's range | 2,476.00 - 2,649.90 |
52-week range | 1,359.55 - 2,652.15 |
Volume | |
Avg. volume | 9,498 |
Market cap | 422.304B |
Beta (5Y monthly) | 0.22 |
PE ratio (TTM) | 79.64 |
EPS (TTM) | 31.30 |
Earnings date | 24 July 2024 - 29 July 2024 |
Forward dividend & yield | 32.00 (1.22%) |
Ex-dividend date | 31 May 2024 |
1y target est | 1,238.59 |
(Bloomberg) -- GSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongside others including Sanofi, must face trials over whether the former heartburn treatment Zantac causes cancer. Most Read from BloombergKey Engines of US Consumer Spending Are Losing Steam All at OnceGameStop Shares Surge as Gill’s Reddit Return Shows Huge BetMnuchin Chases Wall Street Glory With His War Chest of Foreign MoneyHomebuyers Are Starting to Revolt Over Steep Prices Across USAMLO Protege S
(Bloomberg) -- European stocks dropped as investors turned their focus to this week’s earnings from artificial intelligence-bellwether Nvidia Corp. while monitoring for fresh clues on the outlook for interest rates.Most Read from BloombergOne Dead After Singapore Air Flight Hit By Severe Turbulence‘It Felt Like We Had Crashed’: Singapore Air Passenger Describes Turbulence TerrorTesla Shareholder Group Slams Elon Musk’s $56 Billion Pay PackageHims Debuts $199 Weight-Loss Shots at 85% Discount to
(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive officer of GSK Plc found her remedy in a product almost 60 years in the making.Most Read from BloombergOne Dead After Singapore Air Flight Hit By Severe TurbulenceASML, TSMC Can Disable Chip Machines If China Invades TaiwanHims Debuts $199 Weight-Loss Shots at 85% Discount to WegovyJamie Dimon Says Succession at JPMorgan Is ‘Well on the Way’Tesla Shareholder Group Slams Elon Musk’s